Response Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon Resignation of Board Member
2010-03-15 03:08:03
Quote: TheCompany’s Board of Directors presently has eight members, including fourindependent directors.NASDAQNASDAQ deadline on August 9,2010.NASDAQ under the symbol"RGDX."About Response Genetics, Inc.NasdaqRGDXNewswww.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of representatives of RGI related theretocontain or may contain, among other things, certain forward-lookingstatements, within the mea...
Read articleResponse Genetics Announces $4 Million Private Placement
2010-03-15 03:08:03
Quote: Response Genetics, Inc.has agreed to file a registration statement with the SEC covering theresale of the shares of common stock issued in the private placement.This press release shall not constitute an offer to sell or thesolicitation of an offer to buy Response Genetics, Inc.’s common stock.About Response Genetics, Inc.NasdaqRGDXNewswww.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of re...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Stand
2010-03-11 04:55:19
Quote: Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On March 4, 2010, Response Genetics, Inc. (the "Company") received a notice of
deficiency from the NASDAQ Stock Market (NASDAQ). The non-compliance cited by
NASDAQ is the result of Mr. Hubertus Spierings' resignation from the Company
Board of Directors, disclosed in a Report on Form 8-K issued by the Company on
February 9, 2010. With the departure of Mr. Spierings, the Comp...
Read articleResponse Genetics Announces Receipt of NASDAQ Non-Compliance Letter upon Resignation of Board Member
2010-03-11 04:55:19
Quote: TheCompany’s Board of Directors presently has eight members, including fourindependent directors.NASDAQNASDAQ deadline on August 9,2010.NASDAQ under the symbol"RGDX."About Response Genetics, Inc.NasdaqRGDXNewswww.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of representatives of RGI related theretocontain or may contain, among other things, certain forward-lookingstatements, within the mea...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
2010-03-09 04:15:38
Quote: Item 1.01 Entry into a Material Definitive Agreement.
On March 5, 2010, Response Genetics, Inc. (the "Company") entered into a
Purchase Agreement (the "Purchase Agreement") with certain affiliates of and
funds managed by Lansdowne Partners Limited Partnership ( "Lansdowne"), Greenway
Capital Partners and Paragon Associates (the "Purchasers") for the private
placement of 3,005,349 newly-issued shares of the Company's common stock (the
"Shares") a...
Read articleResponse Genetics Announces $4 Million Private Placement
2010-03-09 04:15:38
Quote: Response Genetics, Inc.has agreed to file a registration statement with the SEC covering theresale of the shares of common stock issued in the private placement.This press release shall not constitute an offer to sell or thesolicitation of an offer to buy Response Genetics, Inc.’s common stock.About Response Genetics, Inc.NasdaqRGDXNewswww.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of re...
Read articleResponse Genetics to Increase Sales Force by 50 percent to Meet Growing Demand for its ResponseDX Tests
2010-02-15 04:59:39
Quote: With an internal sales force of 15, as well thenecessary support and infrastructure, the company will be better able tocapitalize on the rapid market acceptance of Response Genetics’personalized medicine solutions.“We’re pleased by the sales ramp of our ResponseDXâ„¢ tests and attributethis success to the decision to expand our sales force in early 2009,â€said Kathleen Danenberg, CEO and president of Response Genetics. “Now,as the benefits of our genetic testin...
Read articleResponse Genetics Inc. Announces Distribution Agreement with Genetic Technologies Ltd. to Expand the Availability of ResponseDX Molecular Diagnostic Tests Internationally
2010-02-15 04:59:39
Quote: Under terms of the agreement,Genetic Technologies will become the exclusive distributor in Australia,Indonesia, Malaysia, the Philippines, Singapore and Thailand forResponse Genetics’ ResponseDX: Colon™, ResponseDX: Lung™ and ResponseDX:Gastric™ genetic test panels. Financial terms were not disclosed.ResponseDX™ tests are proprietary PCR-based tests used to analyze theexpression of genes that correlate with response to commonly usedchemotherapy agents. Since launch...
Read articleResponse Genetics to Present at the 20th Annual UBS Global Healthcare Services Conference and at the 12th Annual BIO CEO & Investor Conference
2010-02-15 04:59:38
Quote: RGDXNewsthth Annual BIO CEO & Investor Conference at theWaldorf-Astoria on February 9, in New York.http://investor.responsegenetics.com/phoenix.zhtml?c=207260&p=irol-presentations].The webcast will be archived for 60 days.About Response Genetics, Inc.www.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of representatives of RGI related theretocontain or may contain, among other things, certain forwar...
Read articleResponse Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors
2010-02-15 04:59:38
Quote: Mitchell to our Board of Directors,†saidKathleen Danenberg, CEO and president of Response Genetics. “Dr.Mitchell’s impressive record of achievement has distinguished her as athought leader in gastrointestinal oncology and personalized medicine.We believe her breadth of clinical experience will provide an importantviewpoint as we continue to grow our company. I would also like toexpress my gratitude to Dr. Gandara for his contributions to the companyand willingness to continue...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers
2010-02-10 01:26:47
Quote: RESPONSE GENETICS INCRequest a Trial to NEW EDGAR Online Pro
Form
8-K for
RESPONSE GENETICS INC
9-Feb-2010Change in Directors or Principal OfficersPrivacy PolicyAbout Our AdsTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors...
Read articleResponse Genetics to Present at the 20th Annual UBS Global Healthcare Services Conference and at the 12th Annual BIO CEO & Investor Conference
2010-02-05 01:20:37
Quote: RGDXNewsthth Annual BIO CEO & Investor Conference at theWaldorf-Astoria on February 9, in New York.http://investor.responsegenetics.com/phoenix.zhtml?c=207260&p=irol-presentations].The webcast will be archived for 60 days.About Response Genetics, Inc.www.responsegenetics.com.Forward-Looking Statement NoticeExcept for the historical information contained herein, this pressrelease and the statements of representatives of RGI related theretocontain or may contain, among other things, certain forwar...
Read articleResponse Genetics Announces Appointment of Dr. Edith P. Mitchell to Board of Directors
2010-01-20 03:39:07
Quote: Mitchell to our Board of Directors,†saidKathleen Danenberg, CEO and president of Response Genetics. “Dr.Mitchell’s impressive record of achievement has distinguished her as athought leader in gastrointestinal oncology and personalized medicine.We believe her breadth of clinical experience will provide an importantviewpoint as we continue to grow our company. I would also like toexpress my gratitude to Dr. Gandara for his contributions to the companyand willingness to continue...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
2010-01-20 03:39:07
Quote: tendered his resignation as
a director of Response Genetics, Inc. (the "Company"), effective as of January
19, 2010. The resignation was not a result of a disagreement with the Company.
The press release issued on January 19, 2010 is filed herewith as Exhibit 99.1.
(d)On January 15, 2010, the board of directors (the "Board") of the
Company elected Edith P. Mitchell to the Board as a director of the Company. The
full text of the press release issued in connection with the appo...
Read articleResponse Genetics to Increase Sales Force by 50 percent to Meet Growing Demand for its ResponseDX Tests
2010-01-12 02:43:43
Quote: With an internal sales force of 15, as well thenecessary support and infrastructure, the company will be better able tocapitalize on the rapid market acceptance of Response Genetics’personalized medicine solutions.“We’re pleased by the sales ramp of our ResponseDXâ„¢ tests and attributethis success to the decision to expand our sales force in early 2009,â€said Kathleen Danenberg, CEO and president of Response Genetics. “Now,as the benefits of our genetic testin...
Read articleResponse Genetics Inc. Announces Distribution Agreement with Genetic Technologies Ltd. to Expand the Availability of ResponseDX Molecular Diagnostic Tests Internationally
2010-01-07 02:00:14
Quote: Under terms of the agreement,Genetic Technologies will become the exclusive distributor in Australia,Indonesia, Malaysia, the Philippines, Singapore and Thailand forResponse Genetics’ ResponseDX: Colon™, ResponseDX: Lung™ and ResponseDX:Gastric™ genetic test panels. Financial terms were not disclosed.ResponseDX™ tests are proprietary PCR-based tests used to analyze theexpression of genes that correlate with response to commonly usedchemotherapy agents. Since launch...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exh
2009-12-15 01:52:17
Quote: Item 4.01Changes In Registrant's Certifying Accountant.
(a)Dismissal of Principal Accountant
On July 14, 2009, Response Genetics, Inc. (the "Company") dismissed SingerLewak
LLP as independent registered public accounting firm for the Company. The
decision to dismiss SingerLewak LLP was approved by the Audit Committee (the
"Audit Committee") of the Board of Directors of the Company.
SingerLewak LLP's audit reports on the Company's consolidated financial
statements for the pas...
Read articleRESPONSE GENETICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec
2009-12-08 04:19:58
Quote: Item 1.01Entry into a Material Definitive Agreement.
On July 22, 2009, Response Genetics, Inc. (the "Company") entered into a
Purchase Agreement (the "Purchase Agreement") with certain funds managed by
Lansdowne Partners Limited Partnership (the "Purchasers") for the private
placement of 3,057,907 newly-issued shares of the Company's common stock (the
"Shares") at a per share price of $1.30 (the "Private Placement").The closing
of the sale of th...
Read articleRESPONSE GENETICS INC Files SEC form 10-Q, Quarterly Report
2009-11-30 06:29:09
Quote: RESPONSE GENETICS INCRequest a Trial to NEW EDGAR Online Pro
Form
10-Q for
RESPONSE GENETICS INC
21-Aug-2009Quarterly ReportPrivacy PolicyTerms of ServiceCopyright/IP PolicySend FeedbackSEC
Filing data and information provided by EDGAR Online,
Inc.
(1-800-416-6651). All information provided "as is"
for informational purposes
only, not intended for trading purposes or advice.
Neither Yahoo! nor any of
independent providers is liable for any informational
errors, incompleteness,
or delays, or for ...
Read articleResponse Genetics Inc. Announces Nationwide Launch of New Gastric Cancer Diagnostic Test to Help Physicians Tailor Therapy for Patients
2009-11-30 06:29:08
Quote: This newest ResponseDX™ test is availablenationwide through the company’s national sales force.“ResponseDX™ tests offer physicians and their patients an objective wayto chart a course of therapy during a very stressful time – the periodbetween diagnosis and the start of treatment,†said Kathleen Danenberg,CEO and president of Response Genetics, Inc. “By personalizing carebased on a tumor’s genetic makeup―as opposed to the “one-size-...
Read article